3/5/2013

Brazil has expanded the role of its regulatory agency Anvisa to enable overseas inspections of medtech suppliers. The move is in response to criticism of the lengthy delays in license approvals experienced by as many as 5,000 domestic and 2,500 foreign firms.

Full Story:
Clinica

Related Summaries